Clinical validation of the CD32b biomarker on the European market

Investigator from Ghent University

Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation

Leukaemia

Catherine Ju-Ying Wu

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

Leukaemia

Crystal Mackall

Immunobiology and Immunotherapy of Pediatric Cancer

Sarcoma Trachea, bronchus and lung Leukaemia

Pediatric oncology or childhood cancer

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Sarcoma Liver and intrahepatic bile ducts Leukaemia

Jeffrey S Miller

Viral priming and targeting NK cells against solid tumor malignancies

Leukaemia

Hematology and hematologic malignancies

Peng Huang

Novel Strategies to Target Leukemia-Stromal Interactions

Leukaemia

Catherine Jenkins

Oncogenic collaboration between RUNX and Notch in T-cell leukemia

Leukaemia

Scott E Evans

Epithelial mechanisms of inducible resistance to AML-associated pneumonia

Leukaemia

Julia E Maxson

Pathogenic Mechanisms of CSF3R Mutations in Leukemia

Leukaemia

Pathology